2013 annual financial data
Tempest Therapeutics 2013 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -29,134,000 USD and net income was -29,044,000 USD.
Operating cash flow was -18,094,000 USD.
Get free Tempest Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -29,134,000 USD
- Net income
- -29,044,000 USD
- Operating cash flow
- -18,094,000 USD